Stock AMGN AMGEN INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Amgen Inc.

Equities

AMGN

US0311621009

Market Closed - Nasdaq
Other stock markets
 04:00:01 2024-05-31 pm EDT 		5-day change 1st Jan Change
305.8 USD +1.59% Intraday chart for Amgen Inc. -0.01% +6.17%
May. 28 US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment RE
May. 28 Amgen's Rare-Disease Treatment Biosimilar Bkemv Gets FDA Approval DJ

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. AMGN Stock
  4. Revisions Amgen Inc.